Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain

被引:105
作者
Sorensen, BB
Freskgård, PO
Nielsen, LS
Rao, LVM
Ezban, M
Petersen, LC
机构
[1] Novo Nordisk AS, Hlth Care Discovery, Tissue Factor Factor VII Res, DK-2760 Malov, Denmark
[2] Univ Texas, Ctr Hlth, Dept Biochem, Tyler, TX 75710 USA
关键词
D O I
10.1074/jbc.274.30.21349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signal transduction induced by activated factor VII (FVIIa) was studied with baby hamster kidney (BHK) cells transfected with human tissue factor (TF), FVIIa induced phosphorylation of p44/42 mitogen-activated protein kinase (MAPK) in cells expressing TF, BHK(+TF), but not in wild-type BHK(-TF) cells. BHK(+TF) cells responded to FVIIa in a dose-dependent manner, with detectable phosphorylation above 10-20 nM FVIIa. BHK cells transfected with a cytoplasmic domain-deleted version of TF, (des248-263)TF, or a C245S substitution variant of TF also supported FVIIa-induced MAPK activation. Experiments with active site-inhibited FVIIa, thrombin, factor Xa, and hirudin confirmed that the catalytic activity of FVIIa was mandatory for p44/42 MAPK activation. Furthermore, a high concentration of FVIIa in complex with soluble TF induced p44/42 MAPK phosphorylation in BHK(-TF) cells. These data suggest that TF was not directly involved in FVIIa-induced p44/42 MAPK phosphorylation but rather served to localize the action of FVIIa to the cell surface, potentially to cleave a cell surface receptor. Desensitization experiments with sequential addition of proteases suggested that the p44/42 MAPK response induced by FVIIa was distinctly different from the thrombin response, possibly involving a novel member of the protease-activated receptor family.
引用
收藏
页码:21349 / 21354
页数:6
相关论文
共 37 条
  • [31] Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor
    Sorensen, BB
    Persson, E
    Freskgard, PO
    Kjalke, M
    Ezban, M
    Williams, T
    Rao, LVM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) : 11863 - 11868
  • [32] Taniguchi T, 1998, CANCER RES, V58, P4461
  • [33] Taubman MB, 1997, THROMB HAEMOSTASIS, V78, P200
  • [34] AMINO-ACID SEQUENCE AND POSTTRANSLATIONAL MODIFICATIONS OF HUMAN FACTOR-VIIA FROM PLASMA AND TRANSFECTED BABY HAMSTER-KIDNEY CELLS
    THIM, L
    BJOERN, S
    CHRISTENSEN, M
    NICOLAISEN, EM
    LUNDHANSEN, T
    PEDERSEN, AH
    HEDNER, U
    [J]. BIOCHEMISTRY, 1988, 27 (20) : 7785 - 7793
  • [35] MOLECULAR-CLONING OF A FUNCTIONAL THROMBIN RECEPTOR REVEALS A NOVEL PROTEOLYTIC MECHANISM OF RECEPTOR ACTIVATION
    VU, TKH
    HUNG, DT
    WHEATON, VI
    COUGHLIN, SR
    [J]. CELL, 1991, 64 (06) : 1057 - 1068
  • [36] Cloning and characterization of human protease-activated receptor 4
    Xu, WF
    Andersen, H
    Whitmore, TE
    Presnell, SR
    Yee, DP
    Ching, A
    Gilbert, T
    Davie, EW
    Foster, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) : 6642 - 6646
  • [37] ZINOCHECK TF, 1992, J BIOL CHEM, V267, P3561